All In Biotech

Drug Trial Radar · NCT05803772

A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test

A Phase II, Randomized, Placebo - Controlled Crossover Proof-of-concept Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation (APHD-012) in Subjects With a Pathological Oral Glucose Tolerance Test (OGTT)

Last checked: Nov 19, 2026Latest source record: Oct 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Mar 31, 2023

Primary completion

Feb 12, 2024

Study completion Feb 12, 2024

Sponsor

Lead sponsor
Aphaia Pharma US LLCIndustry
Sponsor type
Industry
First posted
Apr 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to evaluate the efficacy and safety of APHD-012 (distal jejunal-release dextrose \[Aphaia technology, AT\]) in participants with pre-diabetes (pathological Oral Glucose Tolerance Test (OGTT)).

Conditions

  • PreDiabetes
  • Glucose Tolerance Impaired

Interventions

  • APHD-012Drug

    Drug: APHD-012 Distal jejunal-release dextrose beads (Aphaia technology, AT)

  • APH-012PDrug

    Distal jejunal-release placebo beads

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in AUC0-2h values of Oral Glucose Tolerance Test (OGTT) as measured in blood samplesTime frame: Day 1 to Day 42; Day 71 to Day 112

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • ALIAN, s.r.o.

    Bardejov, Slovakia

  • MEDISPEKTRUM s.r.o.

    Bratislava, Slovakia

  • Cell-B s.r.o.

    Levice, Slovenska, Slovakia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.